A pumping device includes a single-use device and a reusable device. The single-use device is to be inserted into the reusable device and includes two pump units in series, one behind the other. Each pump unit includes a rotor for a bearingless motor, and can be magnetically levitated and driven without contact for rotation about an axial direction. The reusable device includes a stator for each rotor which form an electromagnetic rotary drive for rotating the rotor about the axial direction. Each stator is a bearing and drive stator with which the rotor can be magnetically driven and levitated without contact with respect to the stator. An independent control device is provided for each stator, and can independently activate a respective stator.

An insufflation system includes an insufflation device for supplying gas to a body cavity, and a suction device for suctioning the gas from the body cavity through a suction conduit at a suction flow rate. The insufflation device includes a flow rate sensor for measuring a gas feeding flow rate, a pressure sensor for measuring body cavity internal pressure, a first on-off valve for controlling the gas feeding flow rate, a second on-off valve for opening and closing the suction conduit, and a processor for opening the second on-off valve and controlling the first on-off valve to feed the gas at an amount when a first target gas feeding flow rate calculated from difference between the body cavity internal pressure and insufflation target pressure is lower than a threshold flow rate, the amount being obtained by adding the suction flow rate to the first target gas feeding flow rate.

A peritoneal dialysis (PD) system for infusing a volume of PD solution into a patient's peritoneal cavity in order to perform peritoneal dialysis on the patient includes a peritoneal cavity monitor (PCM) that measures this volume of fluid in the patient's peritoneal cavity by segmental bioimpedance spectroscopy (SBIS), to thereby determine an ultrafiltration volume of fluid in the patient's peritoneal cavity, and a switch, controlled by the PCM, for filling the patient's peritoneal cavity and draining the patient's peritoneal cavity when the ultrafiltration volume is unchanged over time, significantly decreased, or decreasing at a significant rate.

The present invention provides systems, methods, and articles for stress reduction and sleep promotion. A stress reduction and sleep promotion system includes at least one remote device and an article for temperature conditioning a surface. The stress reduction and sleep promotion system includes at least one body sensor, at least one remote server, and/or a pulsed electromagnetic frequency device in other embodiments.

An aerosol delivery system that includes an aerosol generator that aerosolizes a fluid for delivery to a patient as a patient inhales. The aerosol delivery system includes a pump coupled to the aerosol generator that pumps the fluid to the aerosol generator, and a breath sensor that emits a signal as the patient breathes. A controller couples to the aerosol generator, the pump, and the breath sensor. In operation, the controller receives the signal from the breath sensor, controls a flow of fluid to the aerosol generator in response to the signal, and controls the aerosol generator to start aerosolizing the fluid before the patient inhales.

A gas control module for a gas-enhanced electrosurgical system. The gas control module has an inlet port, a first solenoid valve connected to said inlet port, a first pressure sensor, a first pressure regulator, a first flow sensor, a first proportional valve, a second flow sensor, a second solenoid valve, said second solenoid valve being a 3-way valve, a vent connected to said second solenoid valve, a second pressure sensor, a third solenoid valve and an exit port.

Vaporizer devices and methods for detecting inhalation through a vaporizer using a heating element are provided. A resistive heater of a vaporizer may function as both a heater and as an anemometer to detect inhalation. Alternatively or additionally, a separate resistive heater may be included in an air path through the vaporizer to detect a user inhaling through the vaporizer. A heating control mechanism utilizes the already existing heating element in an anemometric correlation to when the vaporizer is idle and when it is being used (where being used implies the user is taking a puff/inhalation on the vaporizer). Using this information, a controller of the vaporizer accordingly controls heating to the vaporizer as required.

An aerosol delivery system that includes an aerosol generator that aerosolizes a fluid for delivery to a patient as a patient inhales. The aerosol delivery system includes a pump coupled to the aerosol generator that pumps the fluid to the aerosol generator, and a breath sensor that emits a signal as the patient breathes. A controller couples to the aerosol generator, the pump, and the breath sensor. In operation, the controller receives the signal from the breath sensor, controls a flow of fluid to the aerosol generator in response to the signal, and controls the aerosol generator to start aerosolizing the fluid before the patient inhales.

A fail-safe drug infusion system, including a user interface controller (UIC) and at least one pump motor controller (PMC), with protocols that enable the PMC to operate therapy delivery for a limited amount of time if the UIC fails or the communication link between the UIC and the PMC is interrupted. Includes synchronization methods to synchronize the delivery information back to the UIC after the UIC reboots or after the communication link is restored. The PMC may apply intelligent fail-safe drug infusion therapy by temporarily displaying therapy information, for example information normally displayed by the UIC, while taking control of alarm signaling and providing minimal user control of the therapy until the UIC restores itself, the infusion completes normally, or the user stops the infusion. If the PMC becomes inoperable, the UIC may wait for the PMC to reboot, or attempt to switch infusion channels to provide robust drug infusion.

A peritoneal dialysis (PD) system for infusing a volume of PD solution into a patient's peritoneal cavity in order to perform peritoneal dialysis on the patient includes a peritoneal cavity monitor (PCM) that measures this volume of fluid in the patient's peritoneal cavity by segmental bioimpedance spectroscopy (SBIS), to thereby determine an ultrafiltration volume of fluid in the patient's peritoneal cavity, and a switch, controlled by the PCM, for filling the patient's peritoneal cavity and draining the patient's peritoneal cavity when the ultrafiltration volume is unchanged over time, significantly decreased, or decreasing at a significant rate.